MENU
UTHR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

United Therapeutics (UTHR) Earnings Date & Reports

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs... Show more

A.I. Advisor
published Earnings

UTHR is expected to report earnings to fall 1.26% to $7.07 per share on February 25

United Therapeutics UTHR Stock Earnings Reports
Q4'25
Est.
$7.07
Q3'25
Missed
by $0.16
Q2'25
Missed
by $0.94
Q1'25
Beat
by $0.10
Q4'24
Missed
by $0.49
The last earnings report on October 29 showed earnings per share of $7.16, missing the estimate of $7.32. With 638.83K shares outstanding, the current market capitalization sits at 21.27B.
View a ticker or compare two or three
UTHR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. UTHR showed earnings on October 29, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com